Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2018-2
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2018-2
HYC
FNCL
HAXNP 2018-2 (USD 56m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
BNP
,
CSI
,
EVR
,
GUO
,
...
APAC
Mar 26, 2018
Missing something? Tell us.